Plain-English translation of NCT06476210 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a combination of three medications—bedaquiline, delamanid, and linezolid—to treat a serious form of tuberculosis that doesn't respond to the usual first-line antibiotics. Researchers want to see whether this medication combination works well and is safe for adults with this hard-to-treat infection. The study will track how many people get better and what side effects occur.
Standard tuberculosis drugs don't work for everyone, leaving some patients with very limited treatment options. This trial exists to see whether this medication combination can be an effective solution for people in China where another similar treatment isn't currently available.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will take the three-medication combination daily for 6 months, with an option to continue for 9 months if you still have active bacteria in your sputum at 4-6 months. During treatment, you'll have regular visits for safety monitoring, blood tests, and sputum samples to check whether the medication is working. After you finish treatment, you'll have a follow-up visit 12 months later to confirm you've recovered and stay healthy.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
China